Correlation between tissue factor pathway inhibitor and coronary artery diseases

PENG Juan,FAN Bing,MA Duan,ZOU Yunzeng,GE Junbo
2013-01-01
Abstract:Objective To determine the level of tissue factor pathway inhibitor ( TFPI ) in the patients with various coronary heart diseases and the changes of TFPI before and after stent implantation , and to explore the correlation between TFPI and coronary artery disease.Methods Totally 120 patients with coronary heart diseases ( stable angina pectoris in 30 , unstable angina pectoris in 35 , acute myocardial infarction in 55 ) were enrolled in this study.All the patients received medications , coronary angiography and interventional therapy. Twenty-one patients without coronary heart diseases confirmed by angiography were taken as controls.Blood samples were taken from peripheral artery before angiography , and from coronary sinus before and immediately after stent implantation.TFPI concentrations were tested with enzyme-linked immunosorbent assay ( ELISA ) . Results TFPI levels in peripheral artery in the patients with acute coronary syndrome ( unstable angina pectoris and acute myocardial infarction ) were significantly lower than those in the patients with stable angina pectoris and without coronary heart diseases ([0.404±0.178] ng / mL vs. [0.517±0.256 ]ng/mL,P<0.05) .There was no significant difference in TFPI levels before and after stent implantation ([0.382±0.140] ng/mL vs. [0.389±0.170]ng/mL,P>0.0 ) .Conclusion The decrease of TFPI levels in patients with acute coronary syndrome suggests abnormalities in tissue factor-mediated coagulation in vivo.TFPI may help understand the severity of coronary heart disease.
What problem does this paper attempt to address?